|
1
|
Perez RP: Cellular and molecular
determinants of cisplatin resistance. Eur J Cancer. 34:1535–1542.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tiseo M, Franciosi V, Grossi F and
Ardizzoni A: Adjuvant chemotherapy for non-small cell lung cancer:
ready for clinical practice? Eur J Cancer. 42:8–16. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Terada K, Nakako T, Yang XL, et al:
Restoration of holoceruloplasmin synthesis in LEC rat after
infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem.
273:1815–1820. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chelly J, Tumer Z, Tonnesen T, et al:
Isolation of a candidate gene for Menkes disease that encodes a
potential heavy metal binding protein. Nat Genet. 3:14–19. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mercer JF, Livingston J, Hall B, et al:
Isolation of a partial candidate gene for Menkes disease by
positional cloning. Nat Genet. 3:20–25. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vulpe C, Levinson B, Whitney S, Packman S
and Gitschier J: Isolation of a candidate gene for Menkes disease
and evidence that it encodes a copper-transporting ATPase. Nat
Genet. 3:7–13. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Safaei R, Holzer AK, Katano K, Samimi G
and Howell SB: The role of copper transporters in the development
of resistance to Pt drugs. J Inorg Biochem. 98:1607–1613. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petris MJ, Strausak D and Mercer JF: The
Menkes copper transporter is required for the activation of
tyrosinase. Hum Mol Genet. 9:2845–2851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Samimi G, Varki NM, Wilczynski S, Safaei
R, Alberts DS and Howell SB: Increase in expression of the copper
transporter ATP7A during platinum drug-based treatment is
associated with poor survival in ovarian cancer patients. Clin
Cancer Res. 9:5853–5859. 2003.PubMed/NCBI
|
|
10
|
Samimi G, Safaei R, Katano K, et al:
Increased expression of the copper efflux transporter ATP7A
mediates resistance to cisplatin, carboplatin, and oxaliplatin in
ovarian cancer cells. Clin Cancer Res. 10:4661–4669. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Safaei R, Katano K, Samimi G, et al:
Cross-resistance to cisplatin in cells with acquired resistance to
copper. Cancer Chemother Pharmacol. 53:239–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kobayashi H, Higashiyama M, Minamigawa K,
et al: Examination of in vitro chemosensitivity test using collagen
gel droplet culture method with colorimetric endpoint
quantification. Jpn J Cancer Res. 92:203–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kobayashi H: Development of a new in vitro
chemosensitivity test using collagen gel droplet embedded culture
and image analysis for clinical usefulness. Recent Results Cancer
Res. 161:48–61. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawamura M, Gika M, Abiko T, et al:
Clinical evaluation of chemosensitivity testing for patients with
unresectable non-small cell lung cancer (NSCLC) using collagen gel
droplet embedded culture drug sensitivity test (CD-DST). Cancer
Chemother Pharmacol. 59:507–513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakagawa T, Inoue Y, Kodama H, et al:
Expression of copper-transporting P-type adenosine triphosphatase
(ATP7B) correlates with cisplatin resistance in human non-small
cell lung cancer xenografts. Oncol Rep. 20:265–270. 2008.PubMed/NCBI
|
|
16
|
Nishi M, Abe Y, Fujimori S, et al: The
modifier subunit of glutamate cysteine ligase relates to cisplatin
resistance in human small-cell lung cancer xenografts in
vivo. Oncol Rep. 14:421–424. 2005.PubMed/NCBI
|
|
17
|
Fujimori S, Abe Y, Nishi M, et al: The
subunits of glutamate cysteine ligase enhance cisplatin resistance
in human non-small cell lung cancer xenografts in vivo. Int
J Oncol. 25:413–418. 2004.PubMed/NCBI
|
